ArticleFrontiers in medicine2025

CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier.

Danyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.